WNT5a in Colorectal Cancer: Research Progress and Challenges

References

• Haggar FA, Boushey RP. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg. 2009;22(04):191–197. doi:10.1055/s-0029-124245821037809
   PubMedGoogle Scholar
• Grizzi F, Bianchi P, Malesci A, Laghi L. Prognostic value of innate and adaptive immunity in colorectal cancer. World J Gastroenterol. 2013;19:174–184. doi:10.3748/wjg.v19.i2.17423345940
   PubMed Web of Science ®Google Scholar
• Johnson CM, Wei C, Ensor JE, et al. Meta-analyses of colorectal cancer risk factors. Cancer Causes Control. 2013;24(6):1207–1222. doi:10.1007/s10552-013-0201-523563998
   PubMed Web of Science ®Google Scholar
• Mengual-Ballester M, Pellicer-Franco E, Valero-Navarro G, Soria-Aledo V, Garcia-Marin JA, Aguayo-Albasini JL. Increased survival and decreased recurrence in colorectal cancer patients diagnosed in a screening programme. Cancer Epidemiol. 2016;43:70–75. doi:10.1016/j.canep.2016.06.00327399311
   PubMed Web of Science ®Google Scholar
• Hubner J, Lewin P, Pritzkuleit R, Eisemann N, Maier W, Katalinic A. Colorectal cancer screening by colonoscopy and trends in disease-specific mortality: a population-based ecological study of 358 German districts. Int J Colorectal Dis. 2019;34(4):599–605. doi:10.1007/s00384-018-03226-630627848
   PubMed Web of Science ®Google Scholar
• Schweiger MR, Hussong M, Rohr C, Lehrach H. Genomics and epigenomics of colorectal cancer. Wiley Interdiscip Rev Syst Biol Med. 2013;5:205–219.23325509
   PubMed Web of Science ®Google Scholar
• Guinney J, Dienstmann R, Wang X, et al. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015;21:1350–1356.26457759
   PubMed Web of Science ®Google Scholar
• Jasperson KW, Tuohy TM, Neklason DW, Burt RW. Hereditary and familial colon cancer. Gastroenterology. 2010;138:2044–2058.20420945
   PubMed Web of Science ®Google Scholar
• Bodmer WF, Bailey CJ, Bodmer J, et al. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature. 1987;328:614–616.3039373
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas N. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487:330–337.22810696
   PubMed Web of Science ®Google Scholar
• Nusse R, Varmus HE. WNT genes. Cell. 1992;69(7):1073–1087. doi:10.1016/0092-8674(92)90630-U1617723
   PubMed Web of Science ®Google Scholar
• Kumawat K, Gosens R. WNT-5a: signaling and functions in health and disease. Cell Mol Life Sci. 2016;73(3):567–587. doi:10.1007/s00018-015-2076-y26514730
   PubMed Web of Science ®Google Scholar
• Clark CC, Cohen I, Eichstetter I, et al. Molecular cloning of the human proto-oncogene WNT-5a and mapping of the gene (WNT5a) to chromosome 3p14-p21. Genomics. 1993;18(2):249–260. doi:10.1006/geno.1993.14638288227
   PubMed Web of Science ®Google Scholar
• Willert K, Nusse R. WNT proteins. Cold Spring Harb Perspect Biol. 2012;4(9):a007864. doi:10.1101/cshperspect.a00786422952392
   PubMed Web of Science ®Google Scholar
• Wong GT, Gavin BJ, McMahon AP. Differential transformation of mammary epithelial cells by WNT genes. Mol Cell Biol. 1994;14:6278–6286. doi:10.1128/MCB.14.9.62788065359
   PubMed Web of Science ®Google Scholar
• Shimizu H, Julius MA, Giarre M, Zheng Z, Brown AM, Kitajewski J. Transformation by WNT family proteins correlates with regulation of beta-catenin. Cell Growth Differ. 1997;8(12):1349–1358.9419423
   PubMedGoogle Scholar
• Jiang W, Crossman DK, Mitchell EH, Sohn P, Crowley MR, Serra R. WNT5a inhibits metastasis and alters splicing of Cd44 in breast cancer cells. PLoS One. 2013;8(3):e58329. doi:10.1371/journal.pone.005832923484019
   PubMed Web of Science ®Google Scholar
• Latres E, Chiaur DS, Pagano M. The human F box protein beta-Trcp associates with the Cul1/Skp1 complex and regulates the stability of beta-catenin. Oncogene. 1999;18:849–854. doi:10.1038/sj.onc.120265310023660
   PubMed Web of Science ®Google Scholar
• Metcalfe C, Mendoza-Topaz C, Mieszczanek J, Bienz M. Stability elements in the LRP6 cytoplasmic tail confer efficient signalling upon DIX-dependent polymerization. J Cell Sci. 2010;123(9):1588–1599. doi:10.1242/jcs.06754620388731
   PubMed Web of Science ®Google Scholar
• Clevers H. WNT/Beta-catenin signaling in development and disease. Cell. 2006;127(3):469–480. doi:10.1016/j.cell.2006.10.01817081971
   PubMed Web of Science ®Google Scholar
• MacDonald BT, Tamai K, He X. WNT/β-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009;17:9–26. doi:10.1016/j.devcel.2009.06.01619619488
   PubMed Web of Science ®Google Scholar
• Tree DRP, Shulman JM, Scott MP, Gubb D, Axelrod JD. Prickle mediates feedback amplification to generate asymmetric planar cell polarity signaling. Cell. 2002;109:371–381. doi:10.1016/S0092-8674(02)00715-812015986
   PubMed Web of Science ®Google Scholar
• Habas R, Kato Y, He X. WNT/frizzled activation of Rho regulates vertebrate gastrulation and requires a novel formin homology protein Daam1. Cell. 2001;107(7):843–854. doi:10.1016/S0092-8674(01)00614-611779461
   PubMed Web of Science ®Google Scholar
• Kikuchi A, Yamamoto H, Sato A, Matsumoto S. New insights into the mechanism of WNT signaling pathway activation. Int Rev Cell Mol Biol. 2011;291:21–71.22017973
   PubMed Web of Science ®Google Scholar
• Gao B, Song H, Bishop K, et al. WNT signaling gradients establish planar cell polarity by inducing Vangl2 phosphorylation through Ror2. Dev Cell. 2011;20(2):163–176. doi:10.1016/j.devcel.2011.01.00121316585
   PubMed Web of Science ®Google Scholar
• Gao C, Chen Y. Dishevelled: the hub of WNT signaling. Cell Signal. 2010;22(5):717–727. doi:10.1016/j.cellsig.2009.11.02120006983
   PubMed Web of Science ®Google Scholar
• Sheldahl LC, Slusarski DC, Pandur P, Miller JR, Kuhl M, Moon RT. Dishevelled activates Ca2+ flux, PKC, and CamKII in vertebrate embryos. J Cell Biol. 2003;161(4):769–777. doi:10.1083/jcb.20021109412771126
   PubMed Web of Science ®Google Scholar
• Albuquerque C, Baltazar C, Filipe B, et al. Colorectal cancers show distinct mutation spectra in members of the canonical WNT signaling pathway according to their anatomical location and type of genetic instability. Genes Chromosomes Cancer. 2010;49(8):746–759. doi:10.1002/gcc.2078620544848
   PubMed Web of Science ®Google Scholar
• Bauer M, Benard J, Gaasterland T, Willert K, Cappellen D. WNT5a encodes two isoforms with distinct functions in cancers. PLoS One. 2013;8:e80526. doi:10.1371/journal.pone.008052624260410
   PubMed Web of Science ®Google Scholar
• Danielson KG, Pillarisetti J, Cohen IR, et al. Characterization of the complete genomic structure of the human WNT-5a gene, functional analysis of its promoter, chromosomal mapping, and expression in early human embryogenesis. J Biol Chem. 1995;270:31225–31234. doi:10.1074/jbc.270.52.312258537388
   PubMed Web of Science ®Google Scholar
• Katula KS, Joyner-Powell NB, Hsu CC, Kuk A. Differential Regulation of the Mouse and Human Wnt5a Alternative Promoters A and B. DNA Cell Biol. 2012;31(11):1585–1597. doi:10.1089/dna.2012.169823046419
   PubMed Web of Science ®Google Scholar
• Mikels AJ, Nusse R. Purified WNT5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLoS Biol. 2006;4:e115. doi:10.1371/journal.pbio.004011516602827
   PubMed Web of Science ®Google Scholar
• Qian D, Jones C, Rzadzinska A, et al. WNT5a functions in planar cell polarity regulation in mice. Dev Biol. 2007;306:121–133. doi:10.1016/j.ydbio.2007.03.01117433286
   PubMed Web of Science ®Google Scholar
• Endo M, Nishita M, Minami Y. Analysis of WNT/planar cell polarity pathway in cultured cells. Methods Mol Biol. 2012;839:201–214.22218903
   PubMedGoogle Scholar
• MacMillan CD, Leong HS, Dales DW, et al. Stage of breast cancer progression influences cellular response to activation of the WNT/planar cell polarity pathway. Sci Rep. 2014. doi:10.1038/srep06315
   PubMed Web of Science ®Google Scholar
• Al-Shawi R, Ashton SV, Underwood C, Simons JP. Expression of the Ror1 and Ror2 receptor tyrosine kinase genes during mouse development. Dev Genes Evol. 2001;211(4):161–171. doi:10.1007/s00427010014011455430
   PubMed Web of Science ®Google Scholar
• Klaus A, Birchmeier W. WNT signalling and its impact on development and cancer. Nat Rev Cancer. 2008;8:387–398.18432252
   PubMed Web of Science ®Google Scholar
• Slusarski DC, Yang-Snyder J, Busa WB, Moon RT. Modulation of embryonic intracellular Ca2+ signaling by WNT-5a. Dev Biol. 1997;182(1):114–120. doi:10.1006/dbio.1996.84639073455
   PubMed Web of Science ®Google Scholar
• Kuhl M, Sheldahl LC, Park M, Miller JR, Moon RT. The WNT/Ca2+ pathway: a new vertebrate WNT signaling pathway takes shape. Trends Genet. 2000;16:279–283.10858654
   PubMed Web of Science ®Google Scholar
• Kuhl M, Sheldahl LC, Malbon CC, Moon RT. Ca2+/calmodulin-dependent protein kinase II is stimulated by WNT and frizzled homologs and promotes ventral cell fates in Xenopus. J Biol Chem. 2000;275(17):12701–12711. doi:10.1074/jbc.275.17.1270110777564
   PubMed Web of Science ®Google Scholar
• Thrasivoulou C, Millar M, Ahmed A. Activation of intracellular calcium by multiple WNT ligands and translocation of β-catenin into the nucleus: a convergent model of WNT/Ca2+ and WNT/β-catenin pathways. J Biol Chem. 2013;288(50):35651–35659. doi:10.1074/jbc.M112.43791324158438
   PubMed Web of Science ®Google Scholar
• Bhatt PM, Malgor R. WNT5a: a player in the pathogenesis of atherosclerosis and other inflammatory disorders. Atherosclerosis. 2014;237(1):155–162. doi:10.1016/j.atherosclerosis.2014.08.02725240110
   PubMed Web of Science ®Google Scholar
• Topol L, Jiang X, Choi H, et al. WNT-5a inhibits the canonical WNT pathway by promoting GSK-3–independent β-catenin degradation. J Cell Biol. 2003;162(5):899–908. doi:10.1083/jcb.20030315812952940
   PubMed Web of Science ®Google Scholar
• McDonald SL, Silver A. The opposing roles of WNT-5a in cancer. Br J Cancer. 2009;101(2):209–214. doi:10.1038/sj.bjc.660517419603030
   PubMed Web of Science ®Google Scholar
• Bakker ER, Das AM, Helvensteijn W, et al. WNT5a promotes human colon cancer cell migration and invasion but does not augment intestinal tumorigenesis in Apc1638N mice. Carcinogenesis. 2013;34(11):2629–2638. doi:10.1093/carcin/bgt21523764752
   PubMed Web of Science ®Google Scholar
• Huang TC, Lee PT, Wu MH, et al. Distinct roles and differential expression levels of WNT5a mRNA isoforms in colorectal cancer cells. PLoS One. 2017;12:e0181034. doi:10.1371/journal.pone.018103428859077
   PubMed Web of Science ®Google Scholar
• Ying J, Li H, Yu J, et al. WNT5a exhibits tumor-suppressive activity through antagonizing the WNT/beta-catenin signaling, and is frequently methylated in colorectal cancer. Clin Cancer Res. 2008;14:55–61. doi:10.1158/1078-0432.CCR-07-164418172252
   PubMed Web of Science ®Google Scholar
• Cheng R, Sun B, Liu Z, et al. WNT5a suppresses colon cancer by inhibiting cell proliferation and epithelial-mesenchymal transition. J Cell Physiol. 2014;229(12):1908–1917. doi:10.1002/jcp.2456624464650
   PubMed Web of Science ®Google Scholar
• Qiu Q, Li Y, Fan Z, et al. Gene Expression Analysis of Human Papillomavirus-Associated Colorectal Carcinoma. Biomed Res Int. 2020;2020:5201587. doi:10.1155/2020/520158732258125
   PubMed Web of Science ®Google Scholar
• Ki DH, Jeung HC, Park CH, et al. Whole genome analysis for liver metastasis gene signatures in colorectal cancer. Int J Cancer. 2007;121(9):2005–2012. doi:10.1002/ijc.2297517640062
   PubMed Web of Science ®Google Scholar
• Barski A, Cuddapah S, Cui K, et al. High-resolution profiling of histone methylations in the human genome. Cell. 2007;129(4):823–837. doi:10.1016/j.cell.2007.05.00917512414
   PubMed Web of Science ®Google Scholar
• Li Q, Chen H. Silencing of Wnt5a during colon cancer metastasis involves histone modifications. Epigenetics. 2012;7(6):551–558. doi:10.4161/epi.2005022522911
   PubMed Web of Science ®Google Scholar
• Belharazem D, Magdeburg J, Berton AK, et al. Carcinoma of the colon and rectum with deregulation of insulin-like growth factor 2 signaling: clinical and molecular implications. J Gastroenterol. 2016;51(10):971–984. doi:10.1007/s00535-016-1181-526984550
   PubMed Web of Science ®Google Scholar
• Issa JP. CpG island methylator phenotype in cancer. Nat Rev Cancer. 2004;4(12):988–993. doi:10.1038/nrc150715573120
   PubMed Web of Science ®Google Scholar
• Galamb O, Kalmar A, Peterfia B, et al. Aberrant DNA methylation of WNT pathway genes in the development and progression of CIMP-negative colorectal cancer. Epigenetics. 2016;11:588–602. doi:10.1080/15592294.2016.119089427245242
   PubMed Web of Science ®Google Scholar
• MacLeod RJ. Extracellular calcium-sensing receptor/PTH knockout mice colons have increased WNT/beta-catenin signaling, reduced non-canonical WNT signaling, and increased susceptibility to azoxymethane-induced aberrant crypt foci. Lab Invest. 2013;93(5):520–527. doi:10.1038/labinvest.2013.5123545937
   PubMed Web of Science ®Google Scholar
• Holcombe RF, Marsh JL, Waterman ML, Lin F, Milovanovic T, Truong T. Expression of WNT ligands and Frizzled receptors in colonic mucosa and in colon carcinoma. Mol Pathol. 2002;55(4):220–226. doi:10.1136/mp.55.4.22012147710
   PubMedGoogle Scholar
• Wang Z, Chen H. Amino acid limitation induces down-regulation of WNT5a at transcriptional level. Biochem Biophys Res Commun. 2009;378(4):789–794. doi:10.1016/j.bbrc.2008.11.12419063862
   PubMed Web of Science ®Google Scholar
• Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19(11):1423–1437. doi:10.1038/nm.339424202395
   PubMed Web of Science ®Google Scholar
• Lopez-Soto A, Gonzalez S, Smyth MJ, Galluzzi L. Control of Metastasis by NK Cells. Cancer Cell. 2017;32:135–154.28810142
   PubMed Web of Science ®Google Scholar
• Jiang Y, Li Y, Zhu B. T-cell exhaustion in the tumor microenvironment. Cell Death Dis. 2015;6:e1792.26086965
   PubMed Web of Science ®Google Scholar
• Noy R, Pollard JW. Tumor-associated macrophages: from mechanisms to therapy. Immunity. 2014;41:49–61.25035953
   PubMed Web of Science ®Google Scholar
• Condeelis J, Pollard JW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell. 2006;124:263–266.16439202
   PubMed Web of Science ®Google Scholar
• Liu Q, Yang C, Wang S, et al. WNT5a-induced M2 polarization of tumor-associated macrophages via IL-10 promotes colorectal cancer progression. Cell Commun Signal. 2020;18:51.32228612
   PubMed Web of Science ®Google Scholar
• Halasi M, Gartel AL. FOX(M1) news–it is cancer. Mol Cancer Ther. 2013;12(3):245–254.23443798
   PubMed Web of Science ®Google Scholar
• Zhou Z, Chen H, Xie R, et al. Epigenetically modulated FOXM1 suppresses dendritic cell maturation in pancreatic cancer and colon cancer. Mol Oncol. 2019;13:873–893.30628173
   PubMed Web of Science ®Google Scholar
• Valenzuela A, Morgado N. Trans fatty acid isomers in human health and in the food industry. Biol Res. 1999;32:273–287.10983247
   PubMed Web of Science ®Google Scholar
• Fujii K, Luo Y, Fujiwara-Tani R, et al. Pro-metastatic intracellular signaling of the elaidic trans fatty acid. Int J Oncol. 2017;50:85–92.27959384
   PubMed Web of Science ®Google Scholar
• Hsu CM, Lin PM, Wang YM, Chen ZJ, Lin SF, Yang MY. Circulating miRNA is a novel marker for head and neck squamous cell carcinoma. Tumour Biol. 2012;33:1933–1942.22811001
   PubMedGoogle Scholar
• Benderska N, Dittrich AL, Knaup S, et al. miRNA-26b overexpression in ulcerative colitis-associated carcinogenesis. Inflamm Bowel Dis. 2015;21:2039–2051.26083618
   PubMed Web of Science ®Google Scholar
• Zhang C, Tong J, Huang G. Nicotinamide phosphoribosyl transferase (Nampt) is a target of microRNA-26b in colorectal cancer cells. PLoS One. 2013;8:e69963.23922874
   PubMed Web of Science ®Google Scholar
• Fan D, Lin X, Zhang F, et al. MicroRNA 26b promotes colorectal cancer metastasis by down regulating phosphatase and tensin homolog and wingless-type MMTV integration site family member 5a. Cancer Sci. 2018;109:354–362.29160937
   PubMed Web of Science ®Google Scholar
• Medrek C, Landberg G, Andersson T, Leandersson K. WNT-5a-CKI{alpha} signaling promotes {beta}-catenin/E-cadherin complex formation and intercellular adhesion in human breast epithelial cells. J Biol Chem. 2009;284:10968–10979.19244247
   PubMed Web of Science ®Google Scholar
• Ma X, Meng Z, Jin L, et al. CAMK2gamma in intestinal epithelial cells modulates colitis-associated colorectal carcinogenesis via enhancing STAT3 activation. Oncogene. 2017;36:4060–4071.28319059
   PubMed Web of Science ®Google Scholar
• Tobimatsu T, Fujisawa H. Tissue-specific expression of four types of rat calmodulin-dependent protein kinase II mRNAs. J Biol Chem. 1989;264:17907–17912.2553697
   PubMed Web of Science ®Google Scholar
• Bui JD, Calbo S, Hayden-Martinez K, Kane LP, Gardner P, Hedrick SM. A role for CaMKII in T cell memory. Cell. 2000;100:457–467.10693762
   PubMed Web of Science ®Google Scholar
• Huang W, Ghisletti S, Saijo K, et al. Coronin 2A mediates actin-dependent de-repression of inflammatory response genes. Nature. 2011;470:414–418.21331046
   PubMed Web of Science ®Google Scholar
• Timmins JM, Ozcan L, Seimon TA, et al. Calcium/calmodulin-dependent protein kinase II links ER stress with Fas and mitochondrial apoptosis pathways. J Clin Invest. 2009;119:2925–2941.19741297
   PubMed Web of Science ®Google Scholar
• Bian Y, Chang X, Liao Y, et al. Promotion of epithelial-mesenchymal transition by Frizzled2 is involved in the metastasis of endometrial cancer. Oncol Rep. 2016;36(2):803–810.27373314
   PubMed Web of Science ®Google Scholar
• Gujral TS, Chan M, Peshkin L, Sorger PK, Kirschner MW, MacBeath G. A noncanonical Frizzled2 pathway regulates epithelial-mesenchymal transition and metastasis. Cell. 2014;159:844–856.25417160
   PubMed Web of Science ®Google Scholar
• Maman S, Witz IP. A history of exploring cancer in context. Nat Rev Cancer. 2018;18:359–376.29700396
   PubMed Web of Science ®Google Scholar
• Vitale I, Manic G, Coussens LM, Kroemer G, Galluzzi L. Macrophages and Metabolism in the Tumor Microenvironment. Cell Metab. 2019;30:36–50.31269428
   PubMed Web of Science ®Google Scholar
• Ruffell B, Affara NI, Coussens LM. Differential macrophage programming in the tumor microenvironment. Trends Immunol. 2012;33:119–126.22277903
   PubMed Web of Science ®Google Scholar
• Lee HW, Choi HJ, Ha SJ, Lee KT, Kwon YG. Recruitment of monocytes/macrophages in different tumor microenvironments. Biochim Biophys Acta. 2013;1835:170–179.23287570
   PubMed Web of Science ®Google Scholar
• Liu Q, Song J, Pan Y, et al. WNT5a/CaMKII/ERK/CCL2 axis is required for tumor-associated macrophages to promote colorectal cancer progression. Int J Biol Sci. 2020;16:1023–1034.32140070
   PubMed Web of Science ®Google Scholar
• Venkatachalam K, Montell C. TRP channels. Annu Rev Biochem. 2007;76:387–417.17579562
   PubMed Web of Science ®Google Scholar
• Chen Z, Tang C, Zhu Y, et al. TrpC5 regulates differentiation through the Ca2+/WNT5a signalling pathway in colorectal cancer. Clin Sci (Lond). 2017;131:227–237.27895148
   PubMed Web of Science ®Google Scholar
• Blume-Jensen P, Hunter T. Oncogenic kinase signalling. Nature. 2001;411:355–365.11357143
   PubMed Web of Science ®Google Scholar
• Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science. 2002;298:1912–1934.12471243
   PubMed Web of Science ®Google Scholar
• Li L, Ying J, Tong X, et al. Epigenetic identification of receptor tyrosine kinase-like orphan receptor 2 as a functional tumor suppressor inhibiting beta-catenin and AKT signaling but frequently methylated in common carcinomas. Cell Mol Life Sci. 2014;71:2179–2192.24158497
   PubMed Web of Science ®Google Scholar
• Mikels A, Minami Y, Nusse R. Ror2 receptor requires tyrosine kinase activity to mediate WNT5a signaling. J Biol Chem. 2009;284:30167–30176.19720827
   PubMed Web of Science ®Google Scholar
• Chen Y, Bellamy WP, Seabra MC, Field MC, Ali BR. ER-associated protein degradation is a common mechanism underpinning numerous monogenic diseases including Robinow syndrome. Hum Mol Genet. 2005;14:2559–2569.16049033
   PubMed Web of Science ®Google Scholar
• Saraswati S, Agrawal SS. Brucine, an indole alkaloid from Strychnos nux-vomica attenuates VEGF-induced angiogenesis via inhibiting VEGFR2 signaling pathway in vitro and in vivo. Cancer Lett. 2013;332:83–93.23348691
   PubMed Web of Science ®Google Scholar
• Shi X, Zhu M, Kang Y, Yang T, Chen X, Zhang Y. WNT/beta-catenin signaling pathway is involved in regulating the migration by an effective natural compound brucine in LoVo cells. Phytomedicine. 2018;46:85–92.30097126
   PubMed Web of Science ®Google Scholar
• Aznar N, Ear J, Dunkel Y, et al. Convergence of WNT, growth factor, and heterotrimeric G protein signals on the guanine nucleotide exchange factor Daple. Sci Signal. 2018;11.
   Web of Science ®Google Scholar
• Mehdawi LM, Prasad CP, Ehrnstrom R, Andersson T, Sjolander A. Non-canonical WNT5a signaling up-regulates the expression of the tumor suppressor 15-PGDH and induces differentiation of colon cancer cells. Mol Oncol. 2016;10:1415–1429.27522468
   PubMed Web of Science ®Google Scholar
• Kuhajda FP. Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition. 2000;16(3):202–208.10705076
   PubMed Web of Science ®Google Scholar
• Wang H, Xi Q, Wu G. Fatty acid synthase regulates invasion and metastasis of colorectal cancer via WNT signaling pathway. Cancer Med. 2016;5:1599–1606.27139420
   PubMed Web of Science ®Google Scholar
• Chi P, Allis CD, Wang GG. Covalent histone modifications – miswritten, misinterpreted and mis-erased in human cancers. Nat Rev Cancer. 2010;10:457–469.20574448
   PubMed Web of Science ®Google Scholar
• Kim KH, Roberts CW. Targeting EZH2 in cancer. Nat Med. 2016;22:128–134. doi:10.1038/nm.403626845405
   PubMed Web of Science ®Google Scholar
• Tao J, Shi L, Huang L, et al. EZH2 is involved in silencing of WNT5a during epithelial-mesenchymal transition of colon cancer cell line. J Cancer Res Clin Oncol. 2017;143(11):2211–2219. doi:10.1007/s00432-017-2479-228748258
   PubMed Web of Science ®Google Scholar
• Wang J, Wang X, Liu F, Fu Y. microRNA-335 inhibits colorectal cancer HCT116 cells growth and epithelial-mesenchymal transition (EMT) process by targeting Twist1. Pharmazie. 2017;72(8):475–481. doi:10.1691/ph.2017.748929441907
   PubMed Web of Science ®Google Scholar
• Yoon JK, Lee JS. Cellular signaling and biological functions of R-spondins. Cell Signal. 2012;24(2):369–377. doi:10.1016/j.cellsig.2011.09.02321982879
   PubMed Web of Science ®Google Scholar
• Wu C, Qiu S, Lu L, et al. RSPO2-LGR5 signaling has tumour-suppressive activity in colorectal cancer. Nat Commun. 2014;5:3149. doi:10.1038/ncomms414924476626
   PubMed Web of Science ®Google Scholar
• Dong X, Liao W, Zhang L, et al. RSPO2 suppresses colorectal cancer metastasis by counteracting the WNT5a/Fzd7-driven noncanonical WNT pathway. Cancer Lett. 2017;402:153–165. doi:10.1016/j.canlet.2017.05.02428600110
   PubMed Web of Science ®Google Scholar
• Truran PP, Johnson SJ, Bliss RD, Lennard TW, Aspinall SR. Parafibromin, galectin-3, PGP9.5, Ki67, and cyclin D1: using an immunohistochemical panel to aid in the diagnosis of parathyroid cancer. World J Surg. 2014;38(11):2845–2854. doi:10.1007/s00268-014-2700-225002250
   PubMed Web of Science ®Google Scholar
• Zheng HC, Wei ZL, Xu XY, et al. Parafibromin expression is an independent prognostic factor for colorectal carcinomas. Hum Pathol. 2011;42(8):1089–1102. doi:10.1016/j.humpath.2010.10.02421315421
   PubMed Web of Science ®Google Scholar
• Shen DF, Liu X, Yang XF, et al. The roles of parafibromin expression in ovarian epithelial carcinomas: a marker for differentiation and prognosis and a target for gene therapy. Tumour Biol. 2016;37(3):2909–2924. doi:10.1007/s13277-015-4103-x26409451
   PubMedGoogle Scholar
• Liu Y, Rubin B, Bodine PV, Billiard J. WNT5a induces homodimerization and activation of Ror2 receptor tyrosine kinase. J Cell Biochem. 2008;105(2):497–502. doi:10.1002/jcb.2184818615587
   PubMed Web of Science ®Google Scholar
• Lee JM, Kim IS, Kim H, et al. RORalpha attenuates WNT/beta-catenin signaling by PKCalpha-dependent phosphorylation in colon cancer. Mol Cell. 2010;37(2):183–195. doi:10.1016/j.molcel.2009.12.02220122401
   PubMed Web of Science ®Google Scholar
• Lin X, Xu W, Shao M, et al. Shenling Baizhu San supresses colitis associated colorectal cancer through inhibition of epithelial-mesenchymal transition and myeloid-derived suppressor infiltration. BMC Complement Altern Med. 2015;15(1):126. doi:10.1186/s12906-015-0649-925897964
   PubMed Web of Science ®Google Scholar
• Wang Z, Chen H. Genistein increases gene expression by demethylation of WNT5a promoter in colon cancer cell line SW1116. Anticancer Res. 2010;30(11):4537–4545.21115903
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chen H. Genistein attenuates WNT signaling by up-regulating sFRP2 in a human colon cancer cell line. Exp Biol Med (Maywood). 2011;236(6):714–722. doi:10.1258/ebm.2011.01034721571909
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li Q, Zhou D, Chen H. Genistein, a soya isoflavone, prevents azoxymethane-induced up-regulation of WNT/beta-catenin signalling and reduces colon pre-neoplasia in rats. Br J Nutr. 2013;109(1):33–42. doi:10.1017/S000711451200087622716201
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li Q, Chen H. DNA methylation and histone modifications of WNT genes by genistein during colon cancer development. Carcinogenesis. 2013;34(8):1756–1763. doi:10.1093/carcin/bgt12923598468
   PubMed Web of Science ®Google Scholar
• Lazarova DL, Bordonaro M, Carbone R, Sartorelli AC. Linear relationship between WNT activity levels and apoptosis in colorectal carcinoma cells exposed to butyrate. Int J Cancer. 2004;110(4):523–531. doi:10.1002/ijc.2015215122584
   PubMed Web of Science ®Google Scholar
• Bordonaro M, Lazarova DL, Sartorelli AC. The activation of beta-catenin by WNT signaling mediates the effects of histone deacetylase inhibitors. Exp Cell Res. 2007;313(8):1652–1666. doi:10.1016/j.yexcr.2007.02.00817359971
   PubMed Web of Science ®Google Scholar
• Bordonaro M, Tewari S, Cicco CE, Atamna W, Lazarova DL. A switch from canonical to noncanonical WNT signaling mediates drug resistance in colon cancer cells. PLoS One. 2011;6:e27308. doi:10.1371/journal.pone.002730822073312
   PubMed Web of Science ®Google Scholar
• Zaid H, Silbermann M, Ben-Arye E, Saad B. Greco-arab and islamic herbal-derived anticancer modalities: from tradition to molecular mechanisms. Evid Based Complement Alternat Med. 2012;2012:349040. doi:10.1155/2012/34904022203868
   PubMed Web of Science ®Google Scholar
• Lansky EP, Newman RA. Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. J Ethnopharmacol. 2007;109(2):177–206. doi:10.1016/j.jep.2006.09.00617157465
   PubMed Web of Science ®Google Scholar
• Mertens-Talcott SU, Jilma-Stohlawetz P, Rios J, Hingorani L, Derendorf H. Absorption, metabolism, and antioxidant effects of pomegranate (punica granatum l.) polyphenols after ingestion of a standardized extract in healthy human volunteers. J Agric Food Chem. 2006;54(23):8956–8961. doi:10.1021/jf061674h17090147
   PubMed Web of Science ®Google Scholar
• Sadik NA, Shaker OG. Inhibitory effect of a standardized pomegranate fruit extract on WNT signalling in 1, 2-dimethylhydrazine induced rat colon carcinogenesis. Dig Dis Sci. 2013;58:2507–2517. doi:10.1007/s10620-013-2704-z23722564
   PubMed Web of Science ®Google Scholar
• Safholm A, Leandersson K, Dejmek J, Nielsen CK, Villoutreix BO, Andersson T. A formylated hexapeptide ligand mimics the ability of WNT-5a to impair migration of human breast epithelial cells. J Biol Chem. 2006;281(5):2740–2749. doi:10.1074/jbc.M50838620016330545
   PubMed Web of Science ®Google Scholar
• Safholm A, Tuomela J, Rosenkvist J, Dejmek J, Harkonen P, Andersson T. The WNT-5a-derived hexapeptide Foxy-5 inhibits breast cancer metastasis in vivo by targeting cell motility. Clin Cancer Res. 2008;14:6556–6563. doi:10.1158/1078-0432.CCR-08-071118927296
   PubMed Web of Science ®Google Scholar
• Osman J, Bellamkonda K, Liu Q, Andersson T, Sjolander A. The WNT5a Agonist Foxy5 Reduces the Number of Colonic Cancer Stem Cells in a Xenograft Mouse Model of Human Colonic Cancer. Anticancer Res. 2019;39:1719–1728. doi:10.21873/anticanres.1327830952711
   PubMed Web of Science ®Google Scholar
• Santoro A, Pisanti S, Grimaldi C, et al. Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon. Int J Cancer. 2009;125:996–1003. doi:10.1002/ijc.2448319479993
   PubMed Web of Science ®Google Scholar
• Gustafsson SB, Lindgren T, Jonsson M, Jacobsson SO. Cannabinoid receptor-independent cytotoxic effects of cannabinoids in human colorectal carcinoma cells: synergism with 5-fluorouracil. Cancer Chemother Pharmacol. 2009;63:691–701. doi:10.1007/s00280-008-0788-518629502
   PubMed Web of Science ®Google Scholar
• Gazzerro P, Malfitano AM, Proto MC, et al. Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin. Oncol Rep. 2010;23:171–175.19956878
   PubMed Web of Science ®Google Scholar
• Proto MC, Fiore D, Piscopo C, et al. Inhibition of WNT/beta-Catenin pathway and Histone acetyltransferase activity by Rimonabant: a therapeutic target for colon cancer. Sci Rep. 2017;7(1):11678. doi:10.1038/s41598-017-11688-x28916833
   PubMed Web of Science ®Google Scholar
• Wei W, Sun HH, Li N, et al. WNT5a modulates cell cycle progression and contributes to the chemoresistance in pancreatic cancer cells. Hepatobiliary Pancreat Dis Int. 2014;13(5):529–538. doi:10.1016/S1499-3872(14)60277-025308364
   PubMed Web of Science ®Google Scholar
• Jiang G, Lin J, Wang W, Sun M, Chen K, Wang F. WNT5a promoter methylation is associated with better responses and longer progression-free survival in colorectal cancer patients treated with 5-fluorouracil-based chemotherapy. Genet Test Mol Biomarkers. 2017;21:74–79. doi:10.1089/gtmb.2016.016228051879
   PubMed Web of Science ®Google Scholar
• Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H. Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment Pharmacol Ther. 2009;30(2):113–125. doi:10.1111/j.1365-2036.2009.04022.x19392870
   PubMed Web of Science ®Google Scholar
• Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ. The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer. 2014;14(5):342–357. doi:10.1038/nrc369124705652
   PubMed Web of Science ®Google Scholar
• Groschel C, Aggarwal A, Tennakoon S, et al. Effect of 1,25-dihydroxyvitamin D3 on the WNT pathway in non-malignant colonic cells. J Steroid Biochem Mol Biol. 2016;155:224–230. doi:10.1016/j.jsbmb.2015.02.01125777538
   PubMed Web of Science ®Google Scholar
• Ghosh-Choudhury N, Mandal CC, Ghosh-Choudhury N, Ghosh Choudhury G. Simvastatin induces derepression of PTEN expression via NFkappaB to inhibit breast cancer cell growth. Cell Signal. 2010;22(5):749–758. doi:10.1016/j.cellsig.2009.12.01020060890
   PubMed Web of Science ®Google Scholar
• Fang Z, Tang Y, Fang J, et al. Simvastatin inhibits renal cancer cell growth and metastasis via AKT/mTOR, ERK and JAK2/STAT3 pathway. PLoS One. 2013;8(5):e62823. doi:10.1371/journal.pone.006282323690956
   PubMed Web of Science ®Google Scholar
• Cho SJ, Kim JS, Kim JM, Lee JY, Jung HC, Song IS. Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice. Int J Cancer. 2008;123(4):951–957. doi:10.1002/ijc.2359318521906
   PubMed Web of Science ®Google Scholar
• Gopalan A, Yu W, Sanders BG, Kline K. Simvastatin inhibition of mevalonate pathway induces apoptosis in human breast cancer cells via activation of JNK/CHOP/DR5 signaling pathway. Cancer Lett. 2013;329(1):9–16. doi:10.1016/j.canlet.2012.08.03122960596
   PubMed Web of Science ®Google Scholar
• Lu L, Huang W, Hu W, et al. Kruppel-like factor 2 mediated anti-proliferative and anti-metastasis effects of simvastatin in p53 mutant colon cancer. Biochem Biophys Res Commun. 2019;511(4):772–779. doi:10.1016/j.bbrc.2019.02.12730833076
   PubMed Web of Science ®Google Scholar
• Ciappio ED, Liu Z, Brooks RS, Mason JB, Bronson RT, Crott JW. Maternal B vitamin supplementation from preconception through weaning suppresses intestinal tumorigenesis in Apc1638N mouse offspring. Gut. 2011;60(12):1695–1702. doi:10.1136/gut.2011.24029121659408
   PubMed Web of Science ®Google Scholar
• Katoh M. WNT/PCP signaling pathway and human cancer (review). Oncol Rep. 2005;14(6):1583–1588.16273260
   PubMed Web of Science ®Google Scholar
• Gao Y, Zhao H, Wang P, et al. The roles of SOCS3 and STAT3 in bacterial infection and inflammatory diseases. Scand J Immunol. 2018;88(6):e12727. doi:10.1111/sji.1272730341772
   PubMed Web of Science ®Google Scholar
• Balanis N, Wendt MK, Schiemann BJ, Wang Z, Schiemann WP, Carlin CR. Epithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathway. J Biol Chem. 2013;288(25):17954–17967. doi:10.1074/jbc.M113.47527723653350
   PubMed Web of Science ®Google Scholar
• Kim JH, Kang GH. Evolving pathologic concepts of serrated lesions of the colorectum. J Pathol Transl Med. 2020;54(4):276–289. doi:10.4132/jptm.2020.04.1532580537
   PubMed Web of Science ®Google Scholar
• Ogino S, Goel A. Molecular classification and correlates in colorectal cancer. J Mol Diagn. 2008;10(1):13–27. doi:10.2353/jmoldx.2008.07008218165277
   PubMed Web of Science ®Google Scholar
• Ogino S, Nosho K, Kirkner GJ, et al. CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut. 2009;58(1):90–96. doi:10.1136/gut.2008.15547318832519
   PubMed Web of Science ®Google Scholar
• Kim JH, Shin SH, Kwon HJ, Cho NY, Kang GH. Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers. Virchows Arch. 2009;455(6):485–494. doi:10.1007/s00428-009-0857-019911194
   PubMed Web of Science ®Google Scholar
• Dahlin AM, Palmqvist R, Henriksson ML, et al. The role of the CpG island methylator phenotype in colorectal cancer prognosis depends on microsatellite instability screening status. Clin Cancer Res. 2010;16:1845–1855. doi:10.1158/1078-0432.CCR-09-259420197478
   PubMed Web of Science ®Google Scholar
• Ribic CM, Sargent DJ, Moore MJ, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med. 2003;349(3):247–257. doi:10.1056/NEJMoa02228912867608
   PubMed Web of Science ®Google Scholar
• Carethers JM, Smith EJ, Behling CA, et al. Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer. Gastroenterology. 2004;126(2):394–401. doi:10.1053/j.gastro.2003.12.02314762775
   PubMed Web of Science ®Google Scholar
• Rawson JB, Mrkonjic M, Daftary D, et al. Promoter methylation of WNT5a is associated with microsatellite instability and BRAF V600E mutation in two large populations of colorectal cancer patients. Br J Cancer. 2011;104(12):1906–1912. doi:10.1038/bjc.2011.16521587258
   PubMed Web of Science ®Google Scholar
• Wang Y. WNT/Planar cell polarity signaling: a new paradigm for cancer therapy. Mol Cancer Ther. 2009;8(8):2103–2109. doi:10.1158/1535-7163.MCT-09-028219671746
   PubMed Web of Science ®Google Scholar
• Dejmek J, Dejmek A, Safholm A, Sjolander A, Andersson T. WNT-5a protein expression in primary dukes B colon cancers identifies a subgroup of patients with good prognosis. Cancer Res. 2005;65(20):9142–9146. doi:10.1158/0008-5472.CAN-05-171016230369
   PubMed Web of Science ®Google Scholar
• Ahn JB, Chung WB, Maeda O, et al. DNA methylation predicts recurrence from resected stage III proximal colon cancer. Cancer. 2011;117(9):1847–1854. doi:10.1002/cncr.2573721509761
   PubMed Web of Science ®Google Scholar
• Kim SH, Park KH, Shin SJ, et al. CpG island methylator phenotype and methylation of wnt pathway genes together predict survival in patients with colorectal cancer. Yonsei Med J. 2018;59(5):588–594. doi:10.3349/ymj.2018.59.5.58829869456
   PubMed Web of Science ®Google Scholar
• Kamposioras K, Konstantara A, Kotoula V, et al. The prognostic significance of WNT pathway in surgically-treated colorectal cancer: beta-catenin expression predicts for disease-free survival. Anticancer Res. 2013;33(10):4573–4584.24123033
   PubMed Web of Science ®Google Scholar